(Q54575673)

1 June 2018

review article

1 reference

title

Molecular analysis of thyroid tumors. (English)

1 reference

1 June 2018

author name string

Feriyl Bhaijee

series ordinal

1

1 reference

1 June 2018

Yuri E Nikiforov

series ordinal

2

1 reference

1 June 2018

publication date

1 September 2011

1 reference

1 June 2018

published in

Endocrine Pathology

1 reference

1 June 2018

volume

22

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

126-133

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s12022-011-9170-y

exact match

0 references

cites work

Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

1 reference

12 December 2020

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

1 reference

12 December 2020

Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

1 reference

12 December 2020

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

1 reference

12 December 2020

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses

1 reference

12 December 2020

Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma

1 reference

12 December 2020

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations

1 reference

12 December 2020

RET/PTC rearrangement in thyroid tumors

1 reference

12 December 2020

Molecular diagnostics and predictors in thyroid cancer

1 reference

12 December 2020

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer

1 reference

12 December 2020

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

1 reference

12 December 2020

Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology

1 reference

12 December 2020

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

1 reference

12 December 2020

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

1 reference

12 December 2020

Activated ras oncogenes in human thyroid cancers

1 reference

12 December 2020

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

1 reference

12 December 2020

Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”

1 reference

12 December 2020

N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

1 reference

12 December 2020

Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer

1 reference

12 December 2020

Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

1 reference

12 December 2020

Alterations of the BRAF gene in thyroid tumors.

1 reference

12 December 2020

Mutation of the PIK3CA gene in anaplastic thyroid cancer.

1 reference

12 December 2020

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

1 reference

12 December 2020

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

1 reference

12 December 2020

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

12 December 2020

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas

1 reference

12 December 2020

Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.

1 reference

12 December 2020

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes

1 reference

12 December 2020

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.

1 reference

12 December 2020

The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults

1 reference

12 December 2020

BRAF mutation in thyroid cancer

1 reference

12 December 2020

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

1 reference

12 December 2020

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

1 reference

12 December 2020

Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement

1 reference

12 December 2020

High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis

1 reference

12 December 2020

Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia

1 reference

12 December 2020

Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma

1 reference

12 December 2020

Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma

1 reference

12 December 2020

Prevalence of Ras mutations in thyroid neoplasia

1 reference

12 December 2020

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

1 reference

12 December 2020

Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications

1 reference

12 December 2020

Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas

1 reference

12 December 2020

Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

1 reference

12 December 2020

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

1 reference

12 December 2020

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

1 reference

12 December 2020

Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications

1 reference

12 December 2020

RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.

1 reference

12 December 2020

Prevalence of activating ras mutations in morphologically characterized thyroid nodules.

1 reference

12 December 2020

The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway

1 reference

12 December 2020

Genetic and biological subgroups of low-stage follicular thyroid cancer

1 reference

12 December 2020

Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer

1 reference

12 December 2020

Presence of mutations in all three ras genes in human thyroid tumors

1 reference

12 December 2020

The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids

1 reference

12 December 2020

Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid

1 reference

12 December 2020

A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma.

1 reference

12 December 2020

Ras oncogene mutations in benign and malignant thyroid neoplasms

1 reference

12 December 2020

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

1 reference

12 December 2020

The prevalence and prognostic value of BRAF mutation in thyroid cancer

1 reference

12 December 2020

Amiodarone-induced thyrotoxicosis and thyroid cancer: clinical, immunohistochemical, and molecular genetic studies of a case and review of the literature

1 reference

12 December 2020

Molecular classification of thyroid nodules using high-dimensionality genomic data

1 reference

12 December 2020

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

1 reference

12 December 2020

ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?

1 reference

12 December 2020

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules

1 reference

12 December 2020

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

12 December 2020

Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas

1 reference

12 December 2020

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

1 reference

12 December 2020

Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice

1 reference

12 December 2020

RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components

1 reference

12 December 2020

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

1 reference

12 December 2020

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

12 December 2020

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

1 reference

12 December 2020

Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas

1 reference

12 December 2020

RET/PTC Rearrangement--a link between Hashimoto's thyroiditis and thyroid cancer...or not

1 reference

12 December 2020

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

1 reference

12 December 2020

Oncogene profile of papillary thyroid carcinoma.

1 reference

12 December 2020

Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?

1 reference

12 December 2020

Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization

1 reference

12 December 2020

Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).

1 reference

12 December 2020

Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin

1 reference

12 December 2020

Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.

1 reference

12 December 2020

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

12 December 2020

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.

1 reference

12 December 2020

Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer

1 reference

12 December 2020

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism

1 reference

12 December 2020

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

1 reference

12 December 2020

RET/PTC oncogene activation is an early event in thyroid carcinogenesis.

1 reference

12 December 2020

BRAF mutations are associated with some histological types of papillary thyroid carcinoma

1 reference

12 December 2020

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

1 reference

12 December 2020

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

1 reference

12 December 2020

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

1 reference

12 December 2020

N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma

1 reference

12 December 2020

N-ras 61 oncogene mutations in Hürthle cell tumors

1 reference

12 December 2020

BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer.

1 reference

12 December 2020

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules

1 reference

12 December 2020

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

1 reference

12 December 2020

Prognostic utility of BRAF mutation in papillary thyroid cancer

1 reference

12 December 2020

RET oncogene activation in papillary thyroid carcinoma.

1 reference

12 December 2020

Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas

1 reference

12 December 2020

BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases

1 reference

12 December 2020

Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas.

1 reference

12 December 2020

10.1007/S12022-011-9170-Y

Identifiers

DOI

1 reference

1 June 2018

release_h77qwq5mabbvpnf2iz3laq5wxu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h77qwq5mabbvpnf2iz3laq5wxu

24 November 2022

mapped directly with Wikidata item

1 reference

1 June 2018